Published in Semin Immunol on December 01, 2011
Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis. J Clin Invest (2013) 1.19
Regulatory B cells: an exciting target for future therapeutics in transplantation. Front Immunol (2014) 0.92
Lymphodepletional strategies in transplantation. Cold Spring Harb Perspect Med (2013) 0.78
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40
A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS (2010) 2.42
Liver transplantation for the treatment of hepatocellular carcinoma. Oncology (Williston Park) (2011) 2.14
Biologics in organ transplantation. Transpl Int (2012) 2.06
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. Transpl Int (2006) 1.68
Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg (2005) 1.67
Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance. J Immunol (2007) 1.64
Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipients. Transpl Int (2013) 1.50
Selenium-binding protein-1 in smooth muscle cells is downregulated in a rhesus monkey model of chronic allograft nephropathy. Am J Transplant (2005) 1.45
Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. Transpl Int (2008) 1.44
Donation after cardiac death: the university of wisconsin experience with renal transplantation. Am J Transplant (2004) 1.26
A cautionary note regarding count models of alcohol consumption in randomized controlled trials. BMC Med Res Methodol (2007) 1.23
Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. J Immunol (2007) 1.23
Risk factors and outcomes in post-liver transplantation bile duct stones and casts: A case-control study. Liver Transpl (2008) 1.23
Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant (2004) 1.19
Overcoming Chronic Rejection-Can it B? Transplantation (2009) 1.17
Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. J Immunol (2004) 1.17
Donation after cardiac death: the University of Wisconsin experience. Ann Transplant (2004) 1.14
Campath-1H use in pediatric renal transplantation. Am J Transplant (2005) 1.13
T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients. Transplantation (2006) 1.12
Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J Immunol (2008) 1.10
The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transpl Int (2006) 1.08
CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor. Immunology (2007) 1.04
Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention. Am J Transplant (2004) 1.03
Underutilization of pancreas donors. Transplantation (2003) 0.98
Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. J Rheumatol (2009) 0.98
Liver transplantation for HELLP syndrome. Liver Transpl (2005) 0.96
Nonhuman primate infections after organ transplantation. ILAR J (2008) 0.95
Assessment of pain and analgesic use in African American cancer patients: factors related to adherence to analgesics. J Immigr Minor Health (2012) 0.94
Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation (2009) 0.94
Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomes. Ann Surg (2005) 0.93
Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice. Exp Biol Med (Maywood) (2003) 0.93
Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model. Transplantation (2004) 0.93
Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction. Transplantation (2004) 0.92
Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection. Hepatology (2012) 0.91
Tolerogenic therapies in transplantation. Front Immunol (2012) 0.88
Racial and socioeconomic disparities in pediatric and young adult liver transplant outcomes. Liver Transpl (2013) 0.88
Interleukin-15 receptor blockade in non-human primate kidney transplantation. Transplantation (2010) 0.87
Surveillance of acute rejection in baboon renal transplantation by elevation of interferon-gamma inducible protein-10 and monokine induced by interferon-gamma in urine. Transplantation (2004) 0.87
Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times. J Surg Oncol (2013) 0.85
The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma. J Vasc Interv Radiol (2010) 0.85
Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation (2003) 0.84
Determination of the functional status of alloreactive T cells by interferon-gamma kinetics. Transplantation (2006) 0.84
Challenging choices: liver transplantation for hepatocellular carcinoma. Ann Surg (2004) 0.83
Superior long-term results of simultaneous pancreas-kidney transplantation from pediatric donors. Am J Transplant (2004) 0.83
The Association Between Hospital Finances and Complications After Complex Abdominal Surgery: Deficiencies in the Current Health Care Reimbursement System and Implications for the Future. Ann Surg (2015) 0.82
Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality. Clin Infect Dis (2004) 0.82
Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation model. Transplantation (2002) 0.82
Urine proteomics in kidney transplantation. Transplant Rev (Orlando) (2013) 0.81
Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells. Int Immunol (2003) 0.81
Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling. J Immunol (2010) 0.80
Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol (2008) 0.80
Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. Transplantation (2003) 0.80
Induction immunosuppression in liver transplantation: a review. Transpl Int (2013) 0.80
A retrospective comparative provider workload analysis for femoral nerve and adductor canal catheters following knee arthroplasty. J Anesth (2014) 0.80
Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. Transplantation (2007) 0.79
Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation. J Immunol (2011) 0.79
Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. Transplantation (2009) 0.79
Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection. Transplantation (2003) 0.79
Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin. Clin Transpl (2006) 0.78
Lymphodepletional strategies in transplantation. Cold Spring Harb Perspect Med (2013) 0.78
Prevention trumps treatment of antibody-mediated transplant rejection. J Clin Invest (2010) 0.77
Long-term outcomes in simultaneous pancreas-kidney transplantation: lessons relearned. Clin Transpl (2003) 0.77
Systems biological analyses reveal the hepatitis C virus (HCV)-specific regulation of hematopoietic development. Hepatology (2015) 0.77
Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft. Transplantation (2015) 0.76
Reply to Vanhove et al. Transpl Int (2013) 0.75
Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta). Exp Toxicol Pathol (2013) 0.75
Cross-talk between T and B Cells in the Germinal Center following Transplantation. Transplantation (2016) 0.75
Incidental living donor nephrectomy: a unique expansion of the donor pool. Nephrol Dial Transplant (2005) 0.75
Annual literature review for clinical transplants 2005. Clin Transpl (2005) 0.75
Starting well: induction immunosuppression after organ transplantation. Transpl Int (2013) 0.75
Cytokine kinetics profiling in pediatric renal transplant recipients. Pediatr Transplant (2010) 0.75
Liver transplantation for biliary atresia: 19-year, single-center experience. Exp Clin Transplant (2004) 0.75
Liver transplantation 2007: where do we go from here? Curr Opin Organ Transplant (2007) 0.75
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders. J Med Chem (2017) 0.75
Immune status assay (ISA): a noninvasive procedure for studying allograft rejection. Transpl Immunol (2004) 0.75
The Volume-outcome Relationship in Deceased Donor Kidney Transplantation and Implications for Regionalization. Ann Surg (2017) 0.75